|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.62 EUR | -0.07% |
|
-2.29% | -11.85% |
| 07:44am | Two approvals for rare diseases in China for Sanofi |  |
| 06:59am | French and Benelux stocks-Factors to watch | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 117B | |||||
| 890B | |||||
| 498B | |||||
| 398B | |||||
| 343B | |||||
| 279B |
- Stock Market
- Equities
- SAN Stock
- Charts Sanofi
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition